Complete Genome Sequence of West Nile Virus Strains Used for the Formulation of CBER/FDA RNA Reference Reagents and Lot Release Panels for Nucleic Acid Testing
We report the complete sequences of two West Nile virus strains (FDA-Hu02 and NY99) used for the formulation of CBER/FDA RNA reference reagents and lot release panels for use with nucleic acid technology testing.
Main Authors: | Grinev, Andriyan, Añez, Germán, Rios, Maria |
---|---|
Format: | Online |
Language: | English |
Published: |
American Society for Microbiology
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214981/ |
Similar Items
-
Complete Coding Region Sequence of a Chikungunya Virus Strain Used for Formulation of CBER/FDA RNA Reference Reagents for Nucleic Acid Testing
by: Añez, Germán, et al.
Published: (2014) -
Complete Genome Sequences of Dengue Virus Type 1 to 4 Strains Used for the Development of CBER/FDA RNA Reference Reagents and WHO International Standard Candidates for Nucleic Acid Testing
by: Añez, Germán, et al.
Published: (2016) -
The Global Ecology and Epidemiology of West Nile Virus
by: Chancey, Caren, et al.
Published: (2015) -
Genetic Analysis of West Nile Virus Isolates from an Outbreak in Idaho, United States, 2006–2007
by: Grinev, Andriyan, et al.
Published: (2013) -
Evolutionary Dynamics of West Nile Virus in the United States, 1999–2011: Phylogeny, Selection Pressure and Evolutionary Time-Scale Analysis
by: Añez, Germán, et al.
Published: (2013)